These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 2933340)
1. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections. Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B Infection; 1985; 13(5):219-24. PubMed ID: 2933340 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections. Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543 [TBL] [Abstract][Full Text] [Related]
4. The comparative in-vitro activity of eight newer quinolones and nalidixic acid. King A; Phillips I J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100 [TBL] [Abstract][Full Text] [Related]
5. The comparative pharmacokinetics of five quinolones. Wise R; Lister D; McNulty CA; Griggs D; Andrews JM J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102 [TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans]. Renaudin H; Quentin C; de Barbeyrac B; Bebear C Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430 [TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile. Edlund C; Nord CE Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556 [TBL] [Abstract][Full Text] [Related]
8. Clinical uses of nalidixic acid analogues: the fluoroquinolones. Høiby N Eur J Clin Microbiol; 1986 Apr; 5(2):138-40. PubMed ID: 3013628 [No Abstract] [Full Text] [Related]
9. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose. Well M; Naber KG; Kinzig-Schippers M; Sörgel F Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule. Wise R; Griggs D; Andrews JM Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin. Van der Auwera P Infection; 1986; 14(3):142-4. PubMed ID: 2942489 [TBL] [Abstract][Full Text] [Related]
12. Clinical use of the quinolones. Neu HC Lancet; 1987 Dec; 2(8571):1319-22. PubMed ID: 2890913 [No Abstract] [Full Text] [Related]
13. [In vitro activity, serum, urine and prostatic adenoma concentrations of ofloxacin in urologic patients with complicated urinary tract infections]. Naber KG; Adam D; Wittenberger R; Bartosik-Wich B Infection; 1986; 14 Suppl 1():S60-4. PubMed ID: 2420725 [TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates. Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910 [TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of newer quinolones against aerobic bacteria. Auckenthaler R; Michéa-Hamzehpour M; Pechère JC J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214 [TBL] [Abstract][Full Text] [Related]
16. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae. Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258 [TBL] [Abstract][Full Text] [Related]
17. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Hooper DC; Wolfson JS Antimicrob Agents Chemother; 1985 Nov; 28(5):716-21. PubMed ID: 2936302 [No Abstract] [Full Text] [Related]
18. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates. Bassey CM; Baltch AL; Smith RP J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401 [TBL] [Abstract][Full Text] [Related]
19. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline. Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317 [TBL] [Abstract][Full Text] [Related]